bg_2

Stand Alone Systems

 

BSP offers the first clinical implementation of the HyperQ technology embedded in advanced stress and rest systems.

 

HyperQ™ EX-300

The HyperQ™ EX-300 is a high quality 12-lead stress ECG system with the unique additional capacity to analyze high frequency components of the ECG signal, thus significantly improving the clinical value of the stress test.

Thousands of patients have been examined using the HyperQ™ EX-300 in controlled clinical studies, pilot programs and routine clinical care. The meticulous, yet intuitive user interface together with state-of-the-art signal processing algorithms and comprehensive reports, provide a high-quality stress system with significantly enhanced diagnostic accuracy.

The HyperQ™ EX-300 received US FDA clearance (510K) and CE marking.

 

stress_1HyperQ™ EX-300

 

 

HyperQ™ AD-100

The HyperQ™ AD-100 is a high resolution ECG system with the unique capacity to analyze high frequency components of the ECG signal, providing more sensitive results and less false alarms.

The HyperQ™ AD-100 is a standalone device which seamlessly integrates with any conventional stress ECG system and provides the unique HyperQ™ analysis.

The HyperQ™ AD-100 received US FDA clearance (510K) and CE marking.

 

rest_1HyperQ™ AD-100

 

 

HyperQ™ Rest

The HyperQ™ Rest is a high quality 12-lead stress ECG system with the unique additional capacity to analyze high frequency components of the ECG signal, allowing physicians in hospitals and primary clinic settings to accurately record and analyze patient’s ECG at rest to assess the presence of suspected Acute coronary Syndrome (ACS), including Myocardial Infarction (MI). The HyperQ Rest has clinical data support from over 1,000 patients.

The system received an FDA clearance on October 2014.

 

rest_1HyperQ™ Rest